Published: 2021-08-24 15:12 | Updated: 2021-08-24 15:33

Current calls, week 34, 2021

Tips from KI Grants Office about current calls.

Swedish and Nordic calls

International postdoc within medicine and health - Swedish Research Council (VR)

Supports research in the field of medicine and health and enables researchers to expand their networks and competencies by working abroad. Grants are worth SEK 1.15 million per year for between 18 months and three years.

Closing date: 14 September 2021

Further information

International postdoc within natural and engineering sciences Swedish Research Council (VR)

Enables researchers in the field of natural and engineering sciences to expand their networks and their competencies by working abroad. Grants are worth SEK 1.15 million per year between 18 months and three years.

Closing date: 14 September 2021

Further information

International research award for mathematics, natural sciences and medicine - Olav Thon Foundation

Recognises excellent research in the field of mathematics, natural sciences and medicine. The award is worth NOK 5 million.

Closing date: 15 September 2021

Further information

Svenska Läkaresällskapet - Stiftelsen Söderström-Königska sjukhemmet

Stiftelsens delar i första hand ut anslag till forskningsprojekt som främjar psykiatrisk kunskapsutveckling (allmänpsykiatri, barn- och ungdomspsykiatri, äldrepsykiatri och rättspsykiatri). Styrelsen kommer vid bedömningen att lägga stor vikt vid nyttan för patienter med psykisk sjukdom samt vid forskning som uppmärksammar kvinnors speciella situation inom psykiatrin. Låg prioritet ges åt ansökningar med djurexperimentell inriktning.

Vid årets ansökningsomgång kan man söka projektanslag och/eller post doktorstöd från stiftelsen.

Closing date: 01 October 2021

Further information

Development projects in incubators 2021 to 2024 – Vinnova

This supports incubators to develop and test new working methods and tools as well as implement already developed working methods and tools that have proven to be effective in incubator operations. Grants are worth up to SEK 2 million and projects may last for up to two years. Maximum award: SEK 2,000,000

Closing date: 5 October 2021

Further information

Challenge programme: immunity at mucosal surfaces – Novo Nordisk Foundation

This supports projects that aim to translate knowledge of the mucosal immune system into novel treatments of disease and develop procedures that safely induce long-lasting protection against pathogens via unspecific immune responses at mucosal surfaces, or that maintain tolerance towards innocuous agents. Grants are worth up to DKK 10 million per year for up to six years. Maximum award: DKK 60,000,000

Closing date: 27 October 2021

Further information

Swedish Pharmaceutical Society

  • Postdoc grants, support post doctoral research in pharmaceutical research either in Sweden or abroad.
  • Travel grants for thesis work abroad from the Elisabeth and Alfred Ahlqvist Foundation
  • Grants for research courses and congresses.
  • Grants for shorter research stays abroad, support doctoral students to stay abroad for a short time.
  • Pharmacies grants for good drug use: supports research projects in outpatient pharmacies.

Closing date: 31 October 2021

Further information

Utlysning av Kungliga och Hvitfeldtskas universitets-och högskolestipendium

Universitets- och högskolestipendium kan tilldelas studerande, som

  • har slutbetyg från gymnasium i förutvarande Göteborg och Bohus län
  • är född i Göteborgs stift eller var folkbokförd där när gymnasiestudierna påbörjades inom stiftet
  • är mindre bemedlad
  • inger goda förhoppningar om framgång i vetenskapliga studier
  • Stipendiet utgör för närvarande 10.000 kronor.

Endast studerande som klarat av minst 60 poäng av grundutbildningen och har för avsikt att examineras vid statlig högskola eller universitet i Sverige samt Handelshögskolan i Stockholm och Chalmers Tekniska Högskola kan komma ifråga för stipendium. En studerande kan endast erhålla stipendiet en gång.

Ansökningshandlingar skall skickas till fonder@ki.se

Closing date: October 9, 2021 

Further information

European calls

Horizon Europe Pillar II collaborative calls

The calls in the Horizon Europe health cluster (Pillar II) aims to contribute to six expected impacts as set out by the strategic plan, which are the following six destinations of this work programme: Destination 1 - Staying healthy in a rapidly changing society. Destination 2 - Living and working in a health-promoting environment. Destination 3 - Tackling diseases and reducing disease burden. Destination 4 - Ensuring access to innovative, sustainable and high-quality health care. Destination 5 - Unlocking the full potential of new tools, technologies and digital solutions for a healthy society. Destination 6 - Maintaining an innovative, sustainable and globally competitive health-related industry.

Opportunities within Pillar II – Health 2022

Two-stage (Research and Innovation action)

Opening date: 06 October 2021

First stage deadline: 01 February 2022

Second stage deadline: 06 September 2022

Single-stage (Research and Innovation action)

Opening date: 12 January 2022

Closing date: 21 April 2022

Fellowship project award - Bayer

Bayer, under its haemophilia awards programme, invites proposals for its fellowship project award. This supports the development of clinical and research expertise in the field of haemophilia for applicants who have completed medical training and have an interest in pursuing a career as a haemophilia clinician.

Applicants should be affiliated with either a medical university, hospital, treatment centre, blood centre or laboratory and should have earned their medical degree within the previous eight years.

Closing date: 30 November 2021

Further information

AO strategy fund - AO Foundation

The AO Foundation invites applications for its strategy fund. This supports the development of innovative products, services and technologies relevant to a clinical area in musculoskeletal disorders. Projects must focus on either clinical tools and technologies for any element of the entire patient journey in musculoskeletal disorders, from diagnosis to post-operative care; or educational tools, platforms or channels for lifelong training of surgeons. Applicants must become members of the AO clinical division. Support is provided in the form of seed funding. There is no pre-defined minimum or maximum amount of funding per project.

Closing date: 31 January 2022

Further information

US calls

Federal Funding agencies

Notice of Special Interest_Understand the Role of DEAD/H-box Helicases in Immune Homeostasis and Activation, NIH

NIAID aims to fund grant awards through the recently issued Notice of Special Interest (NOSI): Understanding the Immune Functions of DEAD/H-box Helicases to promote research examining the role that DEAD/H-box helicases have in immune homeostasis, activation, or function.

Within this NOSI’s scientific focus, projects of interest to NIAID include:

  • Studying the role of DEAD/H-box helicases in immune system development, regulation, and function during homeostasis and in response to antigenic challenge (e.g., pathogens, vaccines, allergens, or autoantigens)
  • Examining small molecule probes or agents targeting DEAD/H-box helicases to further define how these helicases modulate antimicrobial immunity, vaccine responsiveness, immune-mediated diseases, inflammation, immune system development, and tolerance
  • Examining the role and underlying mechanism of DEAD/H-box helicases in hematopoietic stem cells’ self-renewal and differentiation, immune cell production, proliferation, composition, migration, and activation and function.

Closing date: This notice applies to standard due dates on or after October 5, 2021, and subsequent receipt dates through September 7, 2024

Funding Opportunity Announcement (FOA): PA-20-185 (R01), PA-20-195 (R21).

Further information

Technology Development for Single-Molecule Protein Sequencing and Single-Cell Proteome Analysis (R01 Clinical Trial not allowed), NIH

This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing and single cell proteome analysis through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.

Closing date: October 1, 2021; June 15, 2022; June 15, 2023. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-HG-21-001

Further information 

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.

With this FOA, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that use mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally.

Closing date: Standard dates apply until May 08, 2023. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-20-131

Further information 

 

Foundations

2021 - 2022 Request for Proposals, Melanoma Research Alliance (MRA), US

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment.

The 2021 - 2022 award cycle, is anticipated to support at least $11.3 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. 

Closing date:

  • October 6: Team Science Award Letters of Intent Due
  • November 3: Young Investigator Award Eligibility Checklist Due to rfischer@curemelanoma.org.
  • November 17: Young Investigator and Pilot Awards Full Proposals Due
  • January 19: Team Science Award Full Proposals Due (from invited applicants)

Further information 

Brian D Novis research grants, International Myeloma Foundation (IMF), US

The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These grants are provided through donations from private individuals, and are presented annually by the International Myeloma Foundation. These awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis. This year's awards will be $50,000 each for the junior grant and $80,000 for the senior grant.

Closing date: October 1, 2021.

Further information 

Clinical research training scholarship, American Academy of Neurology, US

This award aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies. This award will consist of a commitment of $65,000 per year for two years, plus a $10,000 per year stipend to support education and research-related costs for a total of $150,000. Supplementation of the award with other grants is permissible, but to be eligible to apply for this award, the other grant source(s) cannot exceed $75,000 annually.

Closing date: October 1, 2021

Further information 

Postdoc Fellowship for alternatives to animal research in human health and sex differences, American Fund for Alternatives to Animal Research (AFAAR), US

The American Fund for Alternatives to Animal Research (AFAAR)  offer a $40,000, one-year postdoctoral fellowship grant (with possible renewal) to a woman interested in developing, validating, or using alternatives to animal methods in the investigation of human health or sex differences. Applicants must hold an interest in using or promoting non-animal alternatives in research.

Closing date: October 1, 2021

Further information 

Neuroimaging and cerebrospinal fluid biomarker development programme, Alzheimer’s Drug Discovery Foundation, US

The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use.

Specifically, this RFP focuses on:

  • developing novel PET ligands for clinical trials
  • supporting novel CSF biomarkers
  • validating established MRI approaches in larger cohorts

Awards are typically worth up to USD 600,000 each for a period of one year, with potential for follow-on funding. Multi-year proposals may be considered.

Closing date: October 1, 2021 (LOI), December 3, 2021 (Full proposal).

Further information 

Engagement award – capacity building, Patient-Centred Outcomes Research Institute (PCORI), US

The Engagement Awards program is now accepting Letters of Intent (LOIs) for the Engagement Award: Capacity Building funding opportunity. This opportunity aims to support projects that help communities increase their facility with and ability to participate across all phases of the PCOR/CER process. Applicants may propose projects for up to two years in duration and up to $250,000 in total costs. PCORI reminds prospective applicants that special areas of interest exist to encourage submissions on a topic, not to limit submissions to that topic only. PCORI welcomes Engagement Award: Capacity Building LOIs on all topics related to capacity building for patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) that fall within the guidelines of the program.

Closing date: October 1, 2021 (LOI), January 10, 2022 (Full Proposal).

Further information 

Published: 2021-08-18 12:52 | Updated: 2021-08-18 12:52

Current calls, week 33, 2021

Tips from Grants Office regarding current calls

Swedish and Nordic calls

 

Research grant – Tore Nilsons Foundation for Medical Research

These support clinical medical research. Grants are worth up to SEK 100,000 for a maximum of three years. Researchers who have defended their dissertations no more than five years ago can apply. Researchers who have not yet established themselves as recipients of regular grants from medical research's regular funding bodies are given priority. Maximum award: SEK 100,000

Closing date: 1 September 2021

Further information 

 

Forskningstjänster inom ämnesområdet funktionshinder – Stiftelsen Promobilia

Stiftelsen Promobilia inbjuder ansökningar om anslag till forskningstjänster inom ämnesområdet funktionshinder. Dessa stöder forskare inom ämnesområdet funktionshinder. Forskning från alla discipliner uppmuntras, förutsatt att forskningsområdet involverar utveckling av hjälpmedel för funktionshindrade. Två typer av forskartjänster utlyses: doktorandtjänst med anslagstid två år och möjlighet till förlängning med ytterligare två år eller till disputation, där stöd uppgår till SEK 650,000 per år; postdoktorstjänst, med anslagstid två år och möjlighet till förlängning med ett år, där stöd uppgår till 800,000 per år.

Closing date: 9 September 2021

Further information 

 

Reserach grants – Alzheimer’s Foundation

The Alzheimer's Foundation invites applications for grants for scientific research. This supports research in the field of Alzheimer's disease and other dementia diseases. Eligible to apply are PhD researchers at universities or equivalent educational institutions as well as doctoral students who have completed part-time control. Junior researchers who are in the process of qualifying for an associate professorship are especially encouraged to apply.

Closing date: 10 September 2021

Further information 

 

Research grant in geriatrics – Gun och Bertil Stohne Foundation

This supports a person during their doctoral studies in the subject areas of geriatrics for one year. Grants are usually worth up to SEK 100,000.

Closing date: 13 September 2021

Further information

 

Industrial PhD in the public sector – Innovation Fund Denmark

This aims to give students the opportunity to conduct a research project in partnership with a private company, with the aim of strengthening the relationship between universities and the private sector. Funding partially covers the company’s expenses for the PhD student’s salary and travel-related expenses, as well as the university’s expenses for the project. Maximum award: DKK 1,194,000

Closing date: 21 September 2021

Further information 

 

Mobility Grants for Internationalisation – STINT

This aims to strengthen Swedish research and higher education by developing and establishing international partnerships. The programme supports projects of high scientific quality which are clearly contributing to the activities of participating institutions. Applicants should have obtained their PhD as well as be employed and active at a Swedish university. Projects may last for up to three years. The proposed project must encompass at least one Swedish and at least one foreign party. The foreign party is required to co-fund the project on a corresponding level as applied for from STINT. The principal collaborating party shall be outside the EU/EFTA and the UK.

Closing date: 24 September 2021

Further information 

 

Forskningsanslag – Stiftelsen Läkare Mot AIDS Forskningsfond

Stiftelsen Läkare Mot AIDS Forskningsfond stöder forskning kring HIV-infektion och AIDS, särskilt aspekter avseende behandling och prevention och vaccin. Prioritet ges till projekt som har klinisk anknytning och till sökande som nyligen påbörjat sin forskning. Stöd ges normalt bara till forskning som har en tydlig anknytning till ett svenskt universitet eller sjukhus.

Closing date: 1 October 2021

Further information 

 

Mobility for innovation, learning and knowledge exchange 2021 – Vinnova

Vinnova offers funding to give people active in research and innovation the opportunity to work in an organization other than their current one. The purpose is to strengthen contacts, insights and collaboration as well as competence, knowledge and experience exchanges between organizations through a stay in another organization.

Closing date: 5 October 2021

Further information 

 

Pioneer innovator grants – Novo Nordisk Foundation

These support application-oriented research within the life sciences in order to test ideas that may lead to the development of new medical treatments or health technologies, disease prevention, diagnostic methods, industrial biotechnology or devices. Grants are worth up to DKK 1 million each for 12 months. Maximum award: DKK 1,000,000

Closing date: 8 October 2021

Further information 

European calls

 

Research grants - European Society of Clinical Microbiology and Infectious Diseases


The European Society of Clinical Microbiology and Infectious Diseases invites applications for its research grants. These enable young investigators to conduct research in the fields of infectious diseases and bacterial infections. Research projects may consist of laboratory investigations, clinical studies, experimental animal studies or a combination of these.

Applicants must be principal investigators of the proposed research and must have a medical degree, a PhD or be enrolled in a PhD programme. They must be ESCMID members and must have been born on or after 1 January 1982.

Grants are worth up to €20,000 each over a typical period of 12 months. Two grants, worth €50,000 each, are available for exceptional projects.

Closing date: 10 September 2021

Further information 

 

Research grants - Cure Parkinson’s Trust

The Cure Parkinson’s Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to advance knowledge that might lead to a cure for Parkinson’s disease. Applications must be for research that slows, stops or reverses underlying disease progression. Priority is given to research which has potential to translate into the clinic within five years.

Applications are invited world wide. There is no set financial limit but grants are usually worth between £50,000 to £250,000 each over a period of one to three years.

Closing date: 1 October 2021

Further information 

 

Starting grants - Frick Foundation for ALS Research

The Frick Foundation for ALS Research invites applications for its starting grants. These support basic biomedical research related to amyotrophic lateral sclerosis.

Applicants may be researchers of any nationality with five years of postdoctoral experience and potential to be a research leader. Research must be conducted in a public or private research organisation. Grants are worth CHF 100,000 over two years

Closing date: 30 September 2021

Further information 

 

Global grants for gut health – Nature

Nature, with support from Yakult and Nature Research, invites applications for its global grants for gut health. These support research projects that advance understanding of the role of the early life microbiome in human health.

Researchers who are employed by a university, research institution or any other not-for-profit organisations across the world may apply. Applicants must hold a doctorate or medical degree and have at least five years of postdoctoral research experience. All nationalities are eligible. Up to three grants are available, each worth up to USD 100,000.

Closing date: 15 September 2021

Further information 

US calls

Federal Funding agencies


Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP), Department of Defense, US

To meet the intent of the FY21 TBIPHRP Clinical Research Development Award (CRDA), applications must address at least one sub-area within one of the two FY21 TBIPHRP CRDA Focus Areas listed below. Selection of the appropriate FY21 TBIPHRP CRDA Focus Area is the responsibility of the applicant:

  • Prevent: Research will address the prevention or progression of TBI or psychological health conditions through population, selective, and indicated prevention approaches. Efforts that focus on primary prevention (including protection), screening, diagnosis, and prognosis are within scope.
     
  • Treat: Research will address immediate and long-term treatments and improvements in systems of care, including access to and delivery of healthcare services. Treatment topics may include novel treatments and interventions, personalized medicine approaches, length and durability of treatment, rehabilitation, relapse, and relapse prevention.

There are also other awards available:

  • Clinical Trial Award (CTA): LOI: September 15, 2021. Full Application: December 16, 2021;
  • Focused Program Award (FPA): LOI: September 15, 2021. Full Application: December 16, 2021;
  • Idea Development Award (IDA): LOI: September 8, 2021. Application: September 30, 2021;
  • Investigator-Initiated Research Award (IIRA): LOI: September 8, 2021. Application: September 30, 2021;
  • Translational Research Award (TRA): LOI: September 15, 2021. Full Application: December 16, 2021.

Deadline: Clinical Research Development Award (CRDA): LOI: September 8, 2021. Application: September 30, 2021.

Funding Opportunity Number:  W81XWH-21-TBIPHRP-CRDA

Further information 

 

Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required), NIH

This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions.

Deadline: October 07, 2021, February 10, 2022, October 11, 2022, February 10, 2023, October 10, 2023, February 13, 2024 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-21-307

Further information 

 

Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed), NIH

This FOA invites investigation of biological and clinical measures of TBI-related progressive neurodegeneration and neurocognitive decline associated with increased risk for dementia and /or traumatic encephalopathy syndrome (TES) (clinicopathologic diagnostic counterpart to the neuropathological diagnosis of Chronic Traumatic Encephalopathy (CTE)). Investigations should be based on existing, well-characterized populations of patients with a history of TBI that are enriched for increased risk of cognitive impairment or dementia and can continue to be followed longitudinally; additional subjects may be recruited as appropriate. The overall goal is to advance knowledge of the underlying pathophysiology and clinical characterization of the chronic effects of TBI that distinguish static-chronic TBI cognitive impairment from those that lead to progressive neurodegeneration associated with TES and dementia. A critical feature of this FOA includes the broad sharing of clinical, neuroimaging, physiological, and biospecimen data and to create a data and associated biofluid resource for the broader community to further advance research in this area.

Deadline: November 10, 2021 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-22-024

Further information 

 

Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional), NIH

The purpose of this UG3/UH3 Phased Innovation Award Funding Opportunity Announcement is to support research to understand and respond to the new challenges in treating drug addiction and overdose, introduced by the presence of fentanyl and its analogs (fentanyls) in illicit drug supplies.

Applications should focus on understanding and treating opioid and polydrug use disorders (including overdose), wherein fentanyls are a major contributor and their presence has altered previous estimations of the scope, impact and treatment of the problem. The research may include preclinical, clinical, epidemiological or even post-mortem studies. Studies should have high significance in order to quickly yield improvements in understanding and to provide effective responses to the problems caused by illicit fentanyls.

Deadline: November 10, 2021 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-DA-22-022

Further information 

 

Foundations

CRI Irvington Postdoctoral Fellowship Program, Cancer Research Institute, US

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology. CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor should make every effort to demonstrate the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer. Newly awarded fellowships provide a stipend of $55,000 for the first year, $57,000 for the second year, and $59,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, and/or health insurance.

Deadline: October 1.

Further information

Event type
Lectures and seminars
Webinar: Writing a successful ERC Starting or Consolidator grant proposal (Part 2)

17-09-2021 9:30 am - 11:30 am Add to iCal
Online
Lead

Are you planning to apply to the ERC Starting Grant or Consolidator Grant 2022 calls with KI as host? If so, Grants Office invites you to an online workshop entitled ‘Writing a successful ERC grant proposal’.

Content

The workshop will be led by Dr. Mette Skraastad from Yellow Research, a consultant with extensive experience in supporting ERC applications. The focus will be on how to develop a competitive proposal considering panel specifics and type of project, and how to interpret and address the evaluation criteria. For more information, please see the attached leaflet.

The workshop will consist of two webinars on consecutive days. Attendance is free of charge, but registration is required and registered participants are expected to attend both sessions. Please note that you will also be expected to do a small amount of preparation ahead of the event.

Webinar times:

16th September 2021 09:30 - 11:30 (part 1)

17th September 2021 09:30 - 11:30 (part 2)

To register, please e-mail grantsoffice@ki.se

Contact

Event type
Lectures and seminars
Webinar: Writing a Successful ERC Starting or Consolidator Grant Proposal (Part 1)

16-09-2021 9:30 am - 11:30 am Add to iCal
Online
Lead

Are you planning to apply to the ERC Starting Grant or Consolidator Grant 2022 calls with KI as host? If so, Grants Office invites you to an online workshop entitled ‘Writing a successful ERC grant proposal’.

Content

The workshop will be led by Dr. Mette Skraastad from Yellow Research, a consultant with extensive experience in supporting ERC applications. The focus will be on how to develop a competitive proposal considering panel specifics and type of project, and how to interpret and address the evaluation criteria. For more information, please see the attached leaflet.

The workshop will consist of two webinars on consecutive days. Attendance is free of charge, but registration is required and registered participants are expected to attend both sessions. Please note that you will also be expected to do a small amount of preparation ahead of the event.

Webinar times:

16th September 2021 09:30 - 11:30 (part 1)

17th September 2021 09:30 - 11:30 (part 2)

To register, please e-mail grantsoffice@ki.se

Contact

Published: 2021-07-07 08:35 | Updated: 2021-08-25 17:44

KI researcher receives 38 million SEK for research on Parkinson's disease

Per Svenningsson vid KI får 38 miljoner kronor från Nordstjernan Holding AB och Axel Johnson Gruppen. Foto: Stefan Zimmerman

Professor Per Svenningsson at Karolinska Institutet receives funding for a five-year research project of 38 million SEK from Nordstjernan Holding AB and the Axel Johnson Group. The investment goes to fundamental research on the onset of Parkinson's disease and to clinical studies to improve treatment and slow down the course of the disease.

Dr Xiaoqun Zhang, Antonia Ax:son Johnson from Axel Johnson Group, Göran Ennerfelt from Nordstjernan Holding AB and Per Svenningsson at KI. Photo: Stefan Zimmerman

"We are very pleased to be able to concretely contribute to the research at Karolinska Institutet that focuses on increasing the understanding and treatment of Parkinson's disease", says Göran Ennerfelt, Axel Johnson Group.

"We are pleased to contribute to this investment in developing drugs for a serious disease and reduce the suffering that affects many people around the world", says Kurt Almqvist, Nordstjernan Holding AB.

"The funds enable a pioneering and long-term investment in research on Parkinson's disease at Karolinska Institutet. In addition, the initiative stimulates younger researchers to work in the field, not least by offering opportunities for international collaborations including Harvard Medical School," says Per Svenningsson at the Department of Clinical Neuroscience.

Parkinson's disease is a neurological disease that more than 6 million people in the world suffer from. The diagnosis is based on clinical examination and the presence of stiffness, slowness and tremors, but many patients also suffer from non-motor symptoms. Decreased levels of the neurotransmitter dopamine cause many of the symptoms and can initially be treated with drugs that replace the lost dopamine.

Research on slowing down progression of Parkinson's disease

The next breakthrough in the treatment of Parkinson's disease is a therapy that slows down disease progression. A neuropathological feature of Parkinson's disease is α-synuclein-containing protein aggregates called Lewy bodies. These spread in the brain of people with Parkinson's disease as the disease progresses. Within the framework of this research program, the origin and distribution of Lewy bodies will be studied to identify possible targets for disease modifying therapies.

Published: 2021-06-21 10:42 | Updated: 2021-09-09 08:06

StratNeuro funding for 2021 Collaborative Neuroscience Projects

StratNeuro awards a total of 18 MSEK to six Collaborative Neuroscience Research Projects. 41 letters of intent from across 12 departments were received, of which the top ranking 1/3 (ranging seven departments at KI), were invited to submit full proposals for a second round of evaluation by an external evaluator panel.

The external evaluator panel consisted of the following researchers:

  • David Engblom, Linköping University
  • Cecilia Lindberg, Lund University
  • Paolo Medini, Umeå University
  • Håkan Olausson, Linköping University
  • Åsa Petersén, Lund University
  • Mart Saarma, Helsinki University, Finland

After external evaluation, we are happy to announce that StratNeuro will fund the six top ranked submissions, which represents an overall success rate of 14.6%.

A total of 18 MSEK from the StratNeuro budget has been allocated to fund each project with 3 MSEK.

Grant awardees

Main applicant Konstantinos Ampatzis, Department of Neuroscience and co-applicant, Ilaria Testa, SciLifeLab, The Royal Institute of Technology (KTH).

Project title: "Dynamic neurotransmission in the nervous system: A non-invasive approach to restore the neuronal function"

Main applicant Jonas Frisén, Department of Cell and Molecular Biology and co-applicant Joakim Lundeberg, SciLifeLab, The Royal Institute of Technology (KTH)

Project title: "Clonal and molecular organization of the mouse brain revealed by spatial transcriptomics"

Main applicant Saida Hadjab, Department of Neuroscience and co-applicant, Igor Adameyko, Deparment of Physiology and Pharmacology

Project title: "Molecular Mechanism of Pain Chronification"

Main applicant Robert A. Harris, Department of Clinical Neuroscience and co-applicant Björn Högberg, Department of Medical Biochemistry and Biophysics

Project title: "Novel immunotherapy targeting myeloid cells for neurological diseases: Drug repurposing and nanoengineering"

Main applicant Maja Jagodic, Department of Clinical Neuroscience and co-applicant John Löfblom, Department of Protein Science, The Royal Institute of Technology (KTH)

Project title: "Targeting neuroinflammation and neurodegeneration using artificial ligands"

Main applicant Bertrand Joseph, Institute of Environmental Medicine and co-applicant Sandra Ceccatelli, Department of Neuroscience

Project title: "Roles for microglial diversity in brain development and autism spectrum disorders"

StratNeuro is committed to transparency and gender equality

Out of the 41 letters of intent received, the main applicants were 34% women and 66% men.

The gender ratio of the main applicants in the top 1/3 letters of intent, which were invited to submit full proposals, was 33.33% women and 66.66% men.

The gender ratio of the main applicants in the top 6 ranking proposals awarded the grant was 33.33% women and 66.66% men.

Contact

Published: 2021-06-16 12:58 | Updated: 2021-06-16 13:03

Current calls, week 24, 2021

Tips from Grants Office regarding current calls

Swedish and Nordic calls

 

EU Horizon Europe Research Application Support: Leverage of Swedish Research – the Foundation for Strategic Research (SSF)

Aims to support Swedish researchers in the work of applying for EU grants in the Horizon Europe (HEU) program. The foundation allocates SEK 10 million for applicants who already have ongoing SSF projects or have completed such projects after January 2018. Selected projects will receive SSF-grants maximized to SEK 300 000 or SEK 500 000, depending on the applicant’s role in the proposed future HEU-project. 

Closing date: 1 Sep 2021

Further information 

 

International network grants for the sustainable development goals - Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)

Supports joint projects with one or more global partners outside Europe related to achieving the sustainable development goals. Grants are worth up to SEK 200,000 for up to one year. 

Closing date: 2 Sep 2021

Further information 

 

Mobility for innovation, learning and knowledge exchange - Vinnova

Vinnova offers funding to give people active in research and innovation the opportunity to work in an organization other than their current one. The purpose is to strengthen contacts, insights and collaboration as well as competence, knowledge and experience exchanges between organizations through a stay in another organization. Grants are worth up to SEK 500,000. 

Closing date: 5 Oct 2021

Further information 

 

Project grant - Swedish Society of Nursing

Supports nurses who conduct development and research work, want to start clinical development projects or who are at the beginning of their doctoral education. The total budget is SEK 80,000.

Closing date: 15 Oct 2021

Further information 

European calls

 

ERC-2021-AdG Advanced Grants -- Horizon Europe: Excellent Science, EU and other funders

These support established, leading principal investigators who want long-term funding to pursue a ground-breaking, high-risk project. Applicants should be exceptional leaders in terms of originality and significance of their research contributions, with a track record of significant research achievements in the last ten years.  Applications may be made in any field of research, with an emphasis on the frontiers of science, scholarship and engineering.

Advanced Grants may be awarded up to €2.5 million for a period of 5 years, though an additional € 1 million can be made available under certain circumstances.

If you are interested in applying for an ERC Advanced Grant with KI as host institution, please contact KI Grants Office for further information.

Closing date: 31 August 2021

 

COMING SOON: ERC-2022-SyG Synergy Grants -- Horizon Europe: Excellent Science, EU and other funders

These enable groups of 2-4 principal investigators and their teams to bring together complementary skills, knowledge, and resources in new ways, in order to jointly address ambitious research problems. Each principal investigator must present an early-achievement track record or a 10-year track record. The aim is to promote scientific advances, to cross-fertilise scientific fields, and to encourage new productive lines of enquiry and new methods and techniques, including unconventional approaches and investigations at the interface between established disciplines.

As with individual ERC grants, Synergy Grants fund high-risk high-gain projects, and the sole evaluation criterion is scientific excellence, which in the case the ERC Synergy Grants takes on the additional meaning of outstanding intrinsic synergetic effect.

Synergy Grants can be up to a maximum of €10 million for a period of 6 years. An additional €4 million can be requested under certain circumstances.

If you are interested in applying for an ERC Synergy Grant with KI as host institution, please contact KI Grants Office for further information.

Call dates: The next call is expected to open on 15 July and to close on 10 November 2021.

Further information 

 

Workshops -- European Molecular Biology Organisation, EUR

These enable the organisation of workshops that cover different and evolving aspects of life-science related subject areas, and bring scientists together to present their findings.

Workshops should last between two and a half and five days and attract between 80 and 450 participants. Organisers may be of any nationality and can be based in any country.

Up to €39,000 is available per workshop, where €4,500 are allocated to travel grants and registration fee waivers and €1,000 for childcare grants.

Closing date 1 Aug 2021

Further information 

 

COMING SOON: Global engagement seed grants -- International Brain Research Organization, INT

 These support neuroscience societies, groups and organisations that would like to conduct outreach events and activities in their local areas. The events can include activities such as public lectures and public fairs; advocacy events with policymakers, educators, the media and the public; the development of educational videos or multimedia products to increase awareness; and other similar activities.

Closing date 1 Aug 2021 (Forecast)

Further information 

 

ECCO grants -- European Crohn's and Colitis Organisation, EUR

These support innovative scientific research in the area of inflammatory bowel diseases in Europe.

Young basic or clinical scientists up to the age of 40, or above if within five years of finishing gastrointestinal training or PhD graduation. They must be members of the society

A total of eight awards, worth €80,000 each, are available for one year.

Closing date 2 Aug 2021

Further information 

 

ECCO pioneer award -- European Crohn's and Colitis Organisation, EUR

This aims to encourage and support innovative basic or clinical scientific research in the area of inflammatory bowel diseases across Europe. Projects must be new, original and not yet be launched.

A multi-centre project group or a single centre may apply. All applicants must be members of the organisation.

Two awards €300,000 each for a duration of two years are available.

Closing date 2 Aug 2021

Further information 

US calls

 

Federal Funding agencies

Lupus Research Program (LRP) - Department of Defense, US

The US Department of Defense, under its lupus research programme, invites pre-applications for its idea award. This supports high-risk, high-reward research that could lead to a critical discovery or major advancement relevant to lupus. Clinical trials are not allowed and preliminary data are not required. Research must address at least one of the following focus areas:

  • understanding how lupus disease heterogeneity impacts risk of disease, disease presentation, clinical course and outcomes, including biopsychosocial studies, personalised medicine, variation in treatment studies, health economics, socioeconomic studies, environmental studies, and epidemiological studies;
  • understanding lupus disease heterogeneity, including strategies and technologies to subtype patients and understanding lupus disease mechanisms;
  • improving quality of life for individuals living with lupus;
  • understanding how the underlying genetic components and gene-environment interactions of lupus relate to clinical disease characteristics using functional genomic studies;
  • determining the pathobiology of lupus disease in target human tissues, including imaging studies, genomics of lupus in particular tissues and metabolomics.

The total budget is worth USD 1.2 million to fund approximately four awards. Awards are worth up to USD 300,000 each for up to two years.

Deadline:  Pre-proposals due by August 24, 2021, Full proposal due by September 22, 2021.

Funding Opportunity Number: W81XWH-21-LRP-IA (Idea Award).

Further information

 

Idea Award, Prostate Cancer Research Programme (PCRP), Department of Defense, US

The Department of Defense, under its prostate cancer research programme, invites pre-applications for its idea development award. This supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. Applications must address one or more of the following challenges:

  • improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer;
  • develop treatments that improve outcomes for men with lethal prostate cancer;
  • advance health equity and reduce disparities in prostate cancer;
  • define the biology of lethal prostate cancer to reduce death.

The total budget for this programme is USD 36 million to fund approximately 30 awards worth up to USD 750,000 each. The maximum is three years.

Deadline: Pre-proposals due by 5pm ET, 2 September; applications due by 11.59 ET, 23 September 2021.

Funding Opportunity Number: W81XWH-21-PCRP-IDA

Further information

 

High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed), NIH

This Funding Opportunity Announcement (FOA) will use the R01 funding mechanism to support discrete, specified, and circumscribed projects on novel molecular imaging approaches to establish high-resolution mapping of biomolecules in brain cells and regions during the course of aging and Alzheimer’s disease (AD).

Deadline: October 28, 2021 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-AG-22-019

Further information

 

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed), NIH

Understanding the dynamic activity of brain circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for recording and modulation (including various modalities for stimulation/activation, inhibition and manipulation) of cells (i.e., neuronal and non-neuronal) and networks to enable transformative understanding of dynamic signaling in the central nervous system (CNS). This FOA seeks exceptionally creative approaches to address major challenges associated with recording and modulating CNS activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful, could profoundly change the course of neuroscience research.

Proposed technologies should be compatible with experiments in behaving animals, validated under in vivo experimental conditions, and capable of reducing major barriers to conducting neurobiological experiments and making new discoveries about the CNS. Technologies may engage diverse types of signaling beyond neuronal electrical activity such as optical, magnetic, acoustic and/or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. If suitable, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

Deadline: October 29, 2021, May 02, 2022, October 28, 2022, May 01, 2023, October 27, 2023 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-NS-21-026

Further information 

 

Foundations

Transatlantic networks of excellence in cardiovascular and neurovascular research, Leducq Foundation, US

The Fondation Leducq invites letters of intent for its transatlantic networks of excellence call. This supports collaborative basic, translational and clinical research coordinated by centres in North America and Europe in the fields of cardiovascular and neurovascular disease.

Each application must involve a North America-based and a Europe-based coordinator. Investigators worldwide may participate in the network. A network should have a minimum of three institutional members and a maximum of six. Network coordinators cannot participate in more than one network. Interdisciplinary collaboration is encouraged.

Four grants, each worth up to USD 7 million over five years, are available.

Deadline: September 7, 2021 (LOI); November 1, 2021(Notification); February 14, 2022 (Full proposal); January 1, 2023 (Funding Start).

Further information 

 

Postdoctoral research fellowship, Dravet Syndrome Foundation, US

These awards are designed to support early-career researchers under the mentorship of an independent investigator. These fellowships are awarded to qualified applicants whose proposed projects investigate hypotheses directly related to Dravet syndrome. Proposals are scored according to NIH guidelines based on the quality of preliminary data, research design, feasibility, investigator’s qualifications, and overall impact. Grants are awarded for $50,000 (beginning January 1 of each year), intended to support a full-time research effort with salary and benefits (no indirect costs).

Applicants should ensure their proposed project addresses the needs of the Dravet syndrome community and DSF’s mission to support research toward better treatments and a cure for Dravet syndrome.

Applicants must hold a doctoral degree and be a clinical or postdoctoral fellow at an academic institution anywhere in the world.

The fellowship is worth USD 50,000 for one year.

Deadline: 10 September, 2021 .

Further information 
 

Research grants, Concern Foundation, US

The Concern Foundation is inviting letters of intent for the conquer cancer now awards. These are for young and innovative cancer researchers focused on cancer genetics, cancer biology and cancer immunology. Applicants must be junior faculty at the level of assistant professor and may not be in receipt of any major funding.

A total of 20 grants, worth USD 60,000 each per year for two years, are available.

Deadline: accepting applications starting from July 1, 2021 and with the forecast deadline on 5 September, 2021. This call is repeated every 2 years.

Further information 

Published: 2021-06-15 09:43 | Updated: 2021-06-18 15:11

KI awarded grant for follow-up studies of COVID-19 vaccines

Person with gloves holds vaccine syringe.
Two research environments from Karolinska Institutet have been awarded grants for follow-up studies of COVID-19 vaccines. Foto: Getty Images

Two research environments from Karolinska Institutet have been awarded grants for follow-up studies of COVID-19 vaccines. In total, six research environments from five universities will share SEK 100 million from the Swedish Research Council. The research environments are based on collaborations between different regions, and will focus on different aspects of health and medical care needs.

Research projects from KI that have been awarded grants:

FASTER – National COVID-19 vaccine research platform

A national platform for research into COVID-19 vaccine will be established. Register-based research and clinical trials will form the basis for the evaluation of immune system response, safety and effectiveness of vaccines. The research platform will be a part in the EU collaboration on research into COVID-19 vaccine, VACCELERATE. A national quality register for SARS-CoV-2 will also be established.

Four regions are participating. Pontus Naucler at the Department of Medicine, Solna, is the project leader.

More about the VACCELERATE project
 

COVID-19 vaccination in immuno-suppressed individuals: An interdisciplinary collaboration to obtain clinical and mechanistic insight into lasting immunity against SARS-CoV-2 infection

The study will investigate whether patients with immune system impairment diseases can develop long-term immunity following COVID-19 vaccination, and whether they experience specific side effects. National registers should also be used to examine whether they receive protection against severe covid-19.

Four regions are participating. Soo Aleman at the Department of Medicine, Huddinge, is the project leader.

Subscribe to Funding